|
시장보고서
상품코드
2019785
유세포 분석 시장 규모, 점유율, 성장 및 업계 분석 : 유형 및 용도별, 지역별 인사이트 및 예측(2026-2034년)Flow Cytometry Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
유세포 분석 시장의 성장 요인
첨단 진단 및 연구 도구에 대한 수요가 증가함에 따라 세계 유세포 분석 시장은 강력한 성장세를 보이고 있습니다. 이 시장은 2025년 66억 6,000만 달러로 평가되었고, 2026년에는 72억 2,000만 달러, 2034년에는 141억 2,000만 달러에 달할 것으로 예측됩니다. 이러한 현저한 확대는 질병 진단, 신약 개발 및 임상 연구 분야에서 유세포 분석의 적용 범위가 확대되고 있음을 반영합니다.
유세포 분석은 레이저를 이용한 검출 기술로 세포나 입자의 물리적, 화학적 특성을 측정할 수 있는 강력한 분석 기술입니다. 특히 종양학, 면역학, 감염학 분야에서 세포 계수, 바이오마커 검출 및 질병 진단에 매우 중요한 역할을 하고 있습니다.
시장 동향
시장을 형성하는 주요 트렌드 중 하나는 차세대 유세포 분석 시스템의 개발입니다. 이러한 첨단 장비는 다중 매개변수 분석을 가능하게 하고, 연구자들이 여러 세포 특성을 동시에 조사할 수 있게 해줍니다. 최신 시스템에서는 한 번에 20-30개의 파라미터를 분석할 수 있어 질병 검출의 정확도와 연구 성과 향상에 기여하고 있습니다.
자동화도 중요한 트렌드 중 하나이며, 각 업체들은 효율성과 재현성을 높이기 위해 로봇을 이용한 시료 전처리 시스템 및 통합 솔루션을 도입하고 있습니다. 또한, 고급 소프트웨어와 인공지능의 통합으로 데이터 분석의 효율성을 높이고 임상적 의사결정을 개선하고 있습니다.
시장 성장 요인
유세포 분석 시장의 성장은 주로 암, HIV/AIDS, 백혈병과 같은 만성 질환의 유병률 증가에 의해 주도되고 있습니다. 질병 부담이 증가함에 따라 정확하고 빠른 결과를 제공하는 첨단 진단 기술에 대한 수요가 증가하고 있습니다.
또 다른 중요한 요인은 연구개발에 대한 투자 확대입니다. 제약회사와 생명공학 기업들은 신약개발, 면역종양학, 줄기세포 연구에 유세포분석을 점점 더 많이 활용하고 있습니다. 재조합 DNA 기술 및 항체 기반 연구의 활용 확대도 시장 수요를 더욱 촉진하고 있습니다.
또한, 질병의 조기 진단에 대한 인식 증가와 첨단 검사 기술의 도입은 임상 및 연구 현장에서의 유세포 분석의 보급을 뒷받침하고 있습니다.
억제요인
이러한 장점에도 불구하고, 시장에는 일정한 과제가 존재합니다. 75,000달러에서 100,000달러에 이르는 유세포 분석 장비의 높은 가격은 특히 소규모 실험실이나 개발도상국에서는 도입을 제한하는 요인으로 작용하고 있습니다.
또한, 기술적 복잡성과 숙련된 전문가의 필요성이 보급을 제한하고 있습니다. 장비의 대형화 및 유지보수 요구사항도 시장 성장의 장애요인으로 작용하고 있습니다. 이러한 요인으로 인해 비용에 민감한 시장에서의 도입이 둔화될 수 있습니다.
세분화 분석
제품 및 서비스별
시장 세분화에서는 장비, 소모품 및 시약, 소프트웨어 및 서비스로 구분됩니다. 기기 부문은 분석기 및 셀 분류기에 대한 수요 증가에 힘입어 2026년 50.48%의 점유율을 차지하며 시장을 장악할 것으로 예측됩니다. 이러한 장비의 지속적인 기술 발전이 그 보급을 뒷받침하고 있습니다.
기술별
기술별로 시장은 셀 기반과 비드 기반 시스템으로 분류됩니다. 세포 기반 부문은 질병 진단에 광범위하게 활용되면서 2026년 59.83%의 점유율로 1위를 차지할 것으로 예측됩니다. 반면, 비드 기반 기술은 높은 감도와 비용 효율성으로 인해 급속한 성장이 예상됩니다.
용도별
연구 분야가 가장 큰 비중을 차지하고 있으며, 생명과학 및 생명공학 연구에 대한 투자 증가를 배경으로 2026년에는 70.32%를 차지할 것으로 예측됩니다. 또한, 진단 용도 수요 증가로 인해 임상 분야도 성장하고 있습니다.
최종 사용자별
병원 및 진단실험실은 환자 수 증가와 정확한 진단 도구에 대한 수요 증가에 힘입어 2026년 36.52%의 점유율을 차지하며 이 부문을 주도할 것으로 예측됩니다.
지역별 동향
북미는 주요 기업의 강력한 존재감과 선진화된 의료 인프라를 바탕으로 2025년 39.42%의 점유율을 차지하며 세계 유세포 분석 시장을 주도할 것으로 예측됩니다. 이 지역은 높은 연구개발 투자와 첨단기술의 조기 도입으로 선도적인 지위를 유지하고 있습니다.
유럽은 활발한 연구 활동과 규제 당국의 승인 증가에 힘입어 큰 점유율을 차지하고 있습니다. 아시아태평양은 의료에 대한 인식이 높아지고, 연구 역량이 확대되고, 첨단 진단 도구의 도입이 증가하면서 가장 빠른 성장을 보일 것으로 예측됩니다.
라틴아메리카와 중동 및 아프리카는 의료 인프라 개선과 만성질환 유병률 증가에 힘입어 점차 성장하고 있는 시장입니다.
목차
제1장 서론
제2장 주요 요약
제3장 시장 역학
제4장 주요 인사이트
제5장 세계의 유세포 분석 시장 분석, 인사이트, 예측, 2021년-2034년
제6장 북미의 유세포 분석 시장 분석, 인사이트, 예측, 2021년-2034년
제7장 유럽의 유세포 분석 시장 분석, 인사이트, 예측, 2021년-2034년
제8장 아시아태평양의 유세포 분석 시장 분석, 인사이트, 예측, 2021년-2034년
제9장 세계 기타 지역 유세포 분석 시장 분석, 인사이트, 예측, 2021년-2034년
제10장 경쟁 분석
LSH 26.05.07Growth Factors of flow cytometry Market
The global flow cytometry market is experiencing strong growth due to increasing demand for advanced diagnostic and research tools. The market was valued at USD 6.66 billion in 2025 and is projected to grow to USD 7.22 billion in 2026, reaching USD 14.12 billion by 2034. This significant expansion reflects the growing application of flow cytometry in disease diagnosis, drug discovery, and clinical research.
Flow cytometry is a powerful analytical technology used to measure physical and chemical characteristics of cells or particles using laser-based detection. It plays a crucial role in cell counting, biomarker detection, and disease diagnosis, particularly in oncology, immunology, and infectious diseases.
Market Trends
One of the major trends shaping the market is the development of next-generation flow cytometry systems. These advanced instruments allow multi-parameter analysis, enabling researchers to study multiple cellular characteristics simultaneously. Modern systems can analyze 20-30 parameters at once, improving accuracy in disease detection and research outcomes.
Automation is another key trend, with companies introducing robotic sample preparation systems and integrated solutions that enhance efficiency and reproducibility. Additionally, the integration of advanced software and artificial intelligence is streamlining data analysis and improving clinical decision-making.
Market Growth Drivers
The growth of the flow cytometry market is primarily driven by the increasing prevalence of chronic diseases such as cancer, HIV/AIDS, and leukemia. The rising disease burden has led to higher demand for advanced diagnostic technologies that provide accurate and rapid results.
Another important driver is the growing investment in research and development. Pharmaceutical and biotechnology companies are increasingly using flow cytometry in drug discovery, immuno-oncology, and stem cell research. The expanding use of recombinant DNA technology and antibody-based research is further boosting market demand.
Moreover, the increased awareness regarding early disease diagnosis and the adoption of advanced laboratory technologies are supporting the widespread use of flow cytometry across clinical and research settings.
Restraining Factors
Despite its advantages, the market faces certain challenges. The high cost of flow cytometry instruments, ranging between USD 75,000 and USD 100,000, limits adoption, especially in small laboratories and developing regions.
Additionally, the technical complexity and requirement for skilled professionals restrict its widespread usage. The bulky nature of instruments and maintenance requirements also act as barriers to market growth. These factors may slow down adoption in cost-sensitive markets.
Segmentation Analysis
By Product & Service
The market is segmented into instruments, consumables & reagents, and software & services. The instruments segment dominates with a 50.48% share in 2026, driven by increasing demand for analyzers and cell sorters. Continuous technological advancements in these instruments support their widespread adoption.
By Technology
Based on technology, the market is divided into cell-based and bead-based systems. The cell-based segment leads with a 59.83% share in 2026, owing to its extensive use in disease diagnosis. Meanwhile, bead-based technology is expected to grow rapidly due to its high sensitivity and cost-effectiveness.
By Application
The research segment holds the largest share, accounting for 70.32% in 2026, driven by increasing investments in life sciences and biotechnology research. The clinical segment is also growing due to rising demand for diagnostic applications.
By End-user
Hospitals and diagnostic laboratories dominate the segment with a 36.52% share in 2026, supported by increasing patient visits and growing need for accurate diagnostic tools.
Regional Insights
North America dominates the global flow cytometry market, accounting for 39.42% share in 2025, with a strong presence of key players and advanced healthcare infrastructure. The region continues to lead due to high R&D investments and early adoption of advanced technologies.
Europe holds a significant share, driven by increasing research activities and regulatory approvals. Asia Pacific is expected to witness the fastest growth due to rising healthcare awareness, expanding research capabilities, and increasing adoption of advanced diagnostic tools.
Latin America and the Middle East & Africa are gradually growing markets, supported by improving healthcare infrastructure and rising prevalence of chronic diseases.
Conclusion
The flow cytometry market is set for robust growth, expanding from USD 6.66 billion in 2025 to USD 14.12 billion by 2034. The growth is driven by increasing prevalence of chronic diseases, technological advancements, and rising research activities. While high costs and technical complexities pose challenges, ongoing innovations and expanding applications in clinical and research fields are expected to drive long-term market expansion. Overall, the market presents significant opportunities for stakeholders in the healthcare and life sciences sectors.
Segmentation By Product & Service
- Instruments
- Analyzer
- Sorter
- Reagents & Consumables
- Software & Services
By Technology
- Cell Based
- Bead Based
By Application
- Clinical
- Research
By End-user
- Pharmaceutical & Biotechnology Industries
- Academic & Research Organizations
- Hospital & Diagnostics
- Others
By Geography
- North America (By Product & Service, By Technology, By Application, By Country)
- U.S. (By Application)
- Canada (By Application)
- Europe (By Product & Service, By Technology, By Application, By Country/sub-region)
- Germany (By Application)
- U.K. (By Application)
- France (By Application)
- Italy (By Application)
- Spain (By Application)
- Scandinavia (By Application)
- Rest of Europe (By Application)
- Asia Pacific (By Product & Service, By Technology, By Application, By Country/sub-region)
- China (By Application)
- Japan (By Application)
- India (By Application)
- Australia (By Application)
- Southeast Asia (By Application)
- Rest of Asia Pacific (By Application)
- Rest of the World
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Prevalence of HIV and Cancer, By Key Countries, 2025
- 4.2. Technological Advancements in Flow Cytometry
- 4.3. Key Industry Developments -Mergers, Partnerships, & Acquisitions
- 4.4. Impact of COVID-19 on Global Flow Cytometry Market
5. Global Flow Cytometry Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Product & Service
- 5.1.1. Instruments
- 5.1.1.1. Analyzer
- 5.1.1.2. Sorter
- 5.1.2. Reagents & Consumables
- 5.1.3. Software & Services
- 5.1.1. Instruments
- 5.2. Market Analysis, Insights and Forecast - By Technology
- 5.2.1. Cell Based
- 5.2.2. Bead Based
- 5.3. Market Analysis, Insights and Forecast - By Application
- 5.3.1. Clinical
- 5.3.2. Research
- 5.4. Market Analysis, Insights and Forecast - By End-user
- 5.4.1. Pharmaceuticals & Biotechnology Industries
- 5.4.2. Academic & Research Organizations
- 5.4.3. Hospitals & Diagnostics
- 5.4.4. Others
- 5.5. Market Analysis, Insights and Forecast - By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Rest of the World
6. North America Flow Cytometry Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Product & Service
- 6.1.1. Instruments
- 6.1.1.1. Analyzer
- 6.1.1.2. Sorter
- 6.1.2. Reagents & Consumables
- 6.1.3. Software & Services
- 6.1.1. Instruments
- 6.2. Market Analysis, Insights and Forecast - By Technology
- 6.2.1. Cell Based
- 6.2.2. Bead Based
- 6.3. Market Analysis, Insights and Forecast - By Application
- 6.3.1. Clinical
- 6.3.2. Research
- 6.4. Market Analysis, Insights and Forecast - By End-user
- 6.4.1. Pharmaceuticals & Biotechnology Industries
- 6.4.2. Academic & Research Organizations
- 6.4.3. Hospitals & Diagnostics
- 6.4.4. Others
- 6.5. Market Analysis, Insights and Forecast - By Country
- 6.5.1. U.S.
- 6.5.1.1. By Application
- 6.5.2. Canada
- 6.5.2.1. By Application
- 6.5.1. U.S.
7. Europe Flow Cytometry Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Product & Service
- 7.1.1. Instruments
- 7.1.1.1. Analyzer
- 7.1.1.2. Sorter
- 7.1.2. Reagents & Consumables
- 7.1.3. Software & Services
- 7.1.1. Instruments
- 7.2. Market Analysis, Insights and Forecast - By Technology
- 7.2.1. Cell Based
- 7.2.2. Bead Based
- 7.3. Market Analysis, Insights and Forecast - By Application
- 7.3.1. Clinical
- 7.3.2. Research
- 7.4. Market Analysis, Insights and Forecast - By End-user
- 7.4.1. Pharmaceuticals & Biotechnology Industries
- 7.4.2. Academic & Research Organizations
- 7.4.3. Hospitals & Diagnostics
- 7.4.4. Others
- 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 7.5.1. U.K.
- 7.5.1.1. By Application
- 7.5.2. Germany
- 7.5.2.1. By Application
- 7.5.3. France
- 7.5.3.1. By Application
- 7.5.4. Italy
- 7.5.4.1. By Application
- 7.5.5. Spain
- 7.5.5.1. By Application
- 7.5.6. Scandinavia
- 7.5.6.1. By Application
- 7.5.7. Rest of Europe
- 7.5.7.1. By Application
- 7.5.1. U.K.
8. Asia Pacific Flow Cytometry Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Product & Service
- 8.1.1. Instruments
- 8.1.1.1. Analyzer
- 8.1.1.2. Sorter
- 8.1.2. Reagents & Consumables
- 8.1.3. Software & Services
- 8.1.1. Instruments
- 8.2. Market Analysis, Insights and Forecast - By Technology
- 8.2.1. Cell Based
- 8.2.2. Bead Based
- 8.3. Market Analysis, Insights and Forecast - By Application
- 8.3.1. Clinical
- 8.3.2. Research
- 8.4. Market Analysis, Insights and Forecast - By End-user
- 8.4.1. Pharmaceuticals & Biotechnology Industries
- 8.4.2. Academic & Research Organizations
- 8.4.3. Hospitals & Diagnostics
- 8.4.4. Others
- 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 8.5.1. Japan
- 8.5.1.1. By Application
- 8.5.2. China
- 8.5.2.1. By Application
- 8.5.3. India
- 8.5.3.1. By Application
- 8.5.4. Australia
- 8.5.4.1. By Application
- 8.5.5. Southeast Asia
- 8.5.5.1. By Application
- 8.5.6. Rest of Asia Pacific
- 8.5.6.1. By Application
- 8.5.1. Japan
9. Rest of the World Flow Cytometry Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Product & Service
- 9.1.1. Instruments
- 9.1.1.1. Analyzer
- 9.1.1.2. Sorter
- 9.1.2. Reagents & Consumables
- 9.1.3. Software & Services
- 9.1.1. Instruments
- 9.2. Market Analysis, Insights and Forecast - By Technology
- 9.2.1. Cell Based
- 9.2.2. Bead Based
- 9.3. Market Analysis, Insights and Forecast - By Application
- 9.3.1. Clinical
- 9.3.2. Research
- 9.4. Market Analysis, Insights and Forecast - By End-user
- 9.4.1. Pharmaceuticals & Biotechnology Industries
- 9.4.2. Academic & Research Organizations
- 9.4.3. Hospitals & Diagnostics
- 9.4.4. Others
10. Competitive Analysis
- 10.1. Global Market Share Analysis (2025)
- 10.2. Company Profiles
- 10.2.1. Miltenyi Biotec
- 10.2.1.1. Overview
- 10.2.1.2. Products & Services
- 10.2.1.3. SWOT Analysis
- 10.2.1.4. Recent Developments
- 10.2.1.5. Strategies
- 10.2.1.6. Financials (Based on Availability)
- 10.2.2. BD (Becton, Dickinson and Company)
- 10.2.2.1. Overview
- 10.2.2.2. Products & Services
- 10.2.2.3. SWOT Analysis
- 10.2.2.4. Recent Developments
- 10.2.2.5. Strategies
- 10.2.2.6. Financials (Based on Availability)
- 10.2.3. Bio-Rad Laboratories, Inc.
- 10.2.3.1. Overview
- 10.2.3.2. Products & Services
- 10.2.3.3. SWOT Analysis
- 10.2.3.4. Recent Developments
- 10.2.3.5. Strategies
- 10.2.3.6. Financials (Based on Availability)
- 10.2.4. Thermo Fisher Scientific Inc.
- 10.2.4.1. Overview
- 10.2.4.2. Products & Services
- 10.2.4.3. SWOT Analysis
- 10.2.4.4. Recent Developments
- 10.2.4.5. Strategies
- 10.2.4.6. Financials (Based on Availability)
- 10.2.5. Agilent Technologies, Inc.
- 10.2.5.1. Overview
- 10.2.5.2. Products & Services
- 10.2.5.3. SWOT Analysis
- 10.2.5.4. Recent Developments
- 10.2.5.5. Strategies
- 10.2.5.6. Financials (Based on Availability)
- 10.2.6. Sysmex Corporation
- 10.2.6.1. Overview
- 10.2.6.2. Products & Services
- 10.2.6.3. SWOT Analysis
- 10.2.6.4. Recent Developments
- 10.2.6.5. Strategies
- 10.2.6.6. Financials (Based on Availability)
- 10.2.7. Apogee Flow Systems Ltd.
- 10.2.7.1. Overview
- 10.2.7.2. Products & Services
- 10.2.7.3. SWOT Analysis
- 10.2.7.4. Recent Developments
- 10.2.7.5. Strategies
- 10.2.7.6. Financials (Based on Availability)
- 10.2.8. Sony Biotechnology Inc.
- 10.2.8.1. Overview
- 10.2.8.2. Products & Services
- 10.2.8.3. SWOT Analysis
- 10.2.8.4. Recent Developments
- 10.2.8.5. Strategies
- 10.2.8.6. Financials (Based on Availability)
- 10.2.9. DiaSorin S.p.A.
- 10.2.9.1. Overview
- 10.2.9.2. Products & Services
- 10.2.9.3. SWOT Analysis
- 10.2.9.4. Recent Developments
- 10.2.9.5. Strategies
- 10.2.9.6. Financials (Based on Availability)
- 10.2.10. BIOMERIEUX
- 10.2.10.1. Overview
- 10.2.10.2. Products & Services
- 10.2.10.3. SWOT Analysis
- 10.2.10.4. Recent Developments
- 10.2.10.5. Strategies
- 10.2.10.6. Financials (Based on Availability)
- 10.2.1. Miltenyi Biotec
